OPW
ABBV icon

Oxler Private Wealth’s AbbVie ABBV Stock Holding History

Oxler Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35M Sell
17,280
-34
-0.2% -$7.32K 1.24% 17
2026
Q1 		$3.77M Buy
17,314
+121
+0.7% +$26.8K 1.18% 21
2025
Q4 		$3.93M Buy
17,193
+119
+0.7% +$27.1K 1.14% 19
2025
Q3 		$3.95M Buy
17,074
+72
+0.4% +$14.7K 1.15% 20
2025
Q2 		$3.16M Buy
17,002
+147
+0.9% +$27.3K 0.99% 22
2025
Q1 		$3.53M Buy
16,855
+140
+0.8% +$27.2K 1.24% 23
2024
Q4 		$2.97M Buy
16,715
+44
+0.3% +$8.09K 0.98% 23
2024
Q3 		$3.29M Buy
16,671
+133
+0.8% +$24.8K 1.15% 23
2024
Q2 		$2.84M Buy
16,538
+158
+1% +$26.2K 1.05% 24
2024
Q1 		$2.98M Buy
16,380
+13,122
+403% +$2.26M 1.17% 22
2023
Q4 		$505K Sell
3,258
-12,788
-80% -$1.86M 0.42% 42
2023
Q3 		$2.39M Buy
16,046
+142
+0.9% +$20.8K 1.2% 24
2023
Q2 		$2.14M Sell
15,904
-42
-0.3% -$6.16K 1.02% 28
2023
Q1 		$2.54M Buy
15,946
+151
+1% +$23.1K 1.25% 24
2022
Q4 		$2.55M Buy
+15,795
New +$2.42M 1.37% 25
2022
Q3 		– Sell
-15,495
Closed -$2.37M – 435
2022
Q2 		$2.37M Buy
15,495
+149
+1% +$22.8K 1.14% 26
2022
Q1 		$2.49M Buy
15,346
+148
+1% +$21.5K 1.12% 25
2021
Q4 		$2.06M Hold
15,198
– – 0.85% 33
2021
Q3 		$1.64M Hold
15,198
– – 0.72% 38
2021
Q2 		$1.71M Hold
15,198
– – 0.75% 41
2021
Q1 		$1.64M Buy
15,198
+4,473
+42% +$478K 0.83% 34
2020
Q4 		$1.15M Buy
+10,725
New +$1.03M 0.65% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oxler Private Wealth's ABBV Position: Q2 2026 in Review

Oxler Private Wealth reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $7.32K and leaving 17,280 shares worth $4.35M. The position accounts for 1.24% of the portfolio, ranked #17.

Oxler Private Wealth first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oxler Private Wealth held 17,280 shares of AbbVie worth $4.35M as of Q2 2026.
  • Oxler Private Wealth sold 34 AbbVie shares in Q2 2026, an estimated $7.32K.
  • AbbVie made up 1.24% of Oxler Private Wealth's portfolio in Q2 2026, its #17 holding.
  • Oxler Private Wealth first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oxler Private Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.